Package Insert: Information for the User
Celebrex 200 mg Hard Capsules
celecoxib
Read this package insert carefully before you start taking this medicine, as it contains important information for you.
Celebrex is indicated in adults for alleviating the symptoms and signs ofrheumatoid arthritis, osteoarthritis, andankylosing spondylitis.
The medication will start to take effect a few hours after taking the first dose, but you may not experience a complete effect until several days have passed.
Your doctor has prescribed Celebrex. The following information will help you get better results with Celebrex. If you have any other questions, please ask your doctor or pharmacist.
Do not take Celebrex
Inform your doctor if any of the following circumstances affect you, as patients with these conditions should not take Celebrex:
Warnings and precautions
Consult your doctor or pharmacist before starting to take Celebrex:
Like other anti-inflammatory medications (e.g. ibuprofen or diclofenac), this medication can increase your blood pressure, so your doctor will be able to monitor it regularly.
Some cases of severe liver reactions with celecoxib have been reported, including severe liver inflammation, liver damage, and liver failure (some with fatal outcome or requiring liver transplant).Most of the severe liver reactions occurred in the first month of treatment.
Celebrex may make it difficult to become pregnant. You should inform your doctor if you plan to become pregnant or if you have difficulty becoming pregnant (see section Pregnancy and breastfeeding).
Use of Celebrex with other medications
Inform your doctor or pharmacist if you are using, have used recently, or may need to use any other medication:
Celebrex can be taken with low doses of acetylsalicylic acid (75 mg daily or less). Please consult your doctor before taking both medications together.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
Pregnancy
Celebrex should not be used by pregnant women or women who may become pregnant (i.e. women of childbearing age who do not use an adequate contraceptive method) during treatment. If you become pregnant during treatment with Celebrex, you should discontinue treatment and contact your doctor for alternative treatment.
Breastfeeding
Celebrex should not be used during breastfeeding.
Fertility
NSAIDs, including Celebrex, may make it difficult to become pregnant. You should inform your doctor if you plan to become pregnant or if you are having difficulty becoming pregnant.
Driving and operating machinery
You should know how you react to Celebrex before driving or operating machinery. If you feel dizzy or drowsy after taking Celebrex, do not drive or operate machinery until these effects pass.
Celebrex contains lactose
This medication containslactose(a type of sugar). If your doctor has told you that you have a intolerance to certain sugars, consult with him before taking this medication.
Celebrex contains sodium
This medication contains less than 23 mg ofsodium(1 mmol) per capsule; that is, it is essentially “sodium-free”.
Your doctor will indicate the dose you should take. Since the risk of adverse effects associated with heart problems may increase with the dose and duration of treatment, it is essential to use the lowest dose that controls your pain and do not take Celebrex for longer than necessary to control your symptoms.
Administration form:
Celebrex must be administered orally.The capsules are taken at any time of the day, with or without food. However, try to take each dose of Celebrex at the same time every day.
If you have difficulty swallowing the capsules: you can spread the entire content of the capsule on a teaspoon of some semi-solid food (such as apple sauce, rice, yogurt, or mashed banana at room temperature) and swallow it immediately with a glass of approximately 240 ml of water.
To open the capsule, hold it in a vertical position to keep the granules at the bottom; then, press the top and turn it to extract it, being careful not to spill the content.Do not chew or crush the granules.
Contact your doctor if, after two weeks since the start of treatment, you do not experience an improvement.
Recommended dose:
The recommended dosefor the treatment of arthritisis 200mg per day, if necessary, your doctor may increase it up to a maximum of 400mg.
The recommended dosefor the treatment of rheumatoid arthritisis 200mg per day, if necessary, your doctor may increase it up to a maximum of 400mg.
The usual dose is:
The recommended dosefor the treatment of ankylosing spondylitisis 200mg per day, if necessary, your doctor may increase it up to a maximum of 400mg.
The usual dose is:
Problems in the kidney or liver:make sure your doctor knows if you have problems in the liver or kidney since you may need a lower dose.
Patients over 65 years, especially those weighing less than 50kg:your doctor may want to monitor you more closely if you are over 65years old and especially if you weigh less than50kg.
You should not take more than 400mg per day.
Use in children:
Celebrex is only for adults, it is not indicated for children.
If you take more Celebrex than you should:
You should not take more capsules than indicated by your doctor. If you take more Celebrex than you have been told, consult your doctor, pharmacist, or hospital immediately and bring the medication with you.
If you forget to take Celebrex:
If you forget to take a capsule, take it as soon as you remember. Do not take a double dose to compensate for the missed doses.
If you interrupt the treatment with Celebrex:
Stopping the treatment with Celebrex abruptly may cause a worsening of symptoms. Do not stop taking Celebrex unless your doctor tells you to. Your doctor will indicate that you reduce the dose over a few days before stopping treatment completely.
If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
The side effects listed below were observed in patients with arthritis who took Celebrex. The side effects marked with an asterisk (*) occurred in patients taking Celebrex for the prevention of colon polyps and have been classified according to the highest frequency of occurrence. The patients includedin these studies took Celebrex at high doses and for a prolonged period of time.
If you experience any of the following side effects, discontinue treatment with Celebrex and inform your doctor immediately:
If you have:
Very common side effects: may affect more than 1 in 10 patients:
Common side effects: may affect up to 1 in 10 patients:
Rare side effects: may affect up to 1 in 100 patients:
Very rare side effects: may affect up to 1 in 10,000 patients:
Side effects of unknown frequency: their frequency cannot be estimated from available data:
The side effects reported in clinical trials in which Celebrex was administered at doses of 400mg per day for a period of up to 3 years in patients with non-arthritis-related diseases or other arthritic conditions were:
Common side effects: may affect up to 1 in 10 patients:
Rare side effects: may affect up to 1 in 100 patients:
Reporting of side effects
If you experienceany type of side effect, consult your doctor or pharmacist, even if it is apossibleside effect that does not appear in this prospectus.You can also report them directly through theSpanish System for the Pharmacovigilance of Medicinal Products for Human Use:http://www.notificaram.es.By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears onthe blister pack and on the packaging.The expiration date is the last day of the month indicated.
Do not store at a temperature above30 °C.
Medications should not be disposed of through drains or in the trash. Dispose of packaging and medications you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of packaging and medications you no longer need. By doing so, you will help protect the environment.
The active ingredient is celecoxib.
Each capsule contains 200 mg of celecoxib.
The other components (excipients) are:
Lactose monohydrate, sodium lauryl sulfate, povidone, croscarmellose sodium, magnesium stearate. The capsule coating contains gelatin, titanium dioxide (E-171), sodium lauryl sulfate, and monolaurate of sorbitan. The printing ink contains shellac lacquer, propylene glycol, and iron oxide (E-172).
Appearance of the product and packaging contents
Celebrex is presented in the form of capsules.
The capsules are opaque, white, with two golden bands, and bear the marks “7767”and “200”.
The capsules are presented in a transparent or opaque PVC/aluminum blister.
Celebrex may be presented in packaging sizes of 2, 5, 6, 10, 20, 30, 40, 50, 60, 100, 10x10, 10x30, 10x50, 1x50 single-dose, 1x100 single-dose, and 5 x (10x10).
Only some packaging sizes may be commercially marketed.
Marketing authorization holder and responsible manufacturer
Marketing authorization holder
Viatris Healthcare Limited
Damastown Industrial Park
Mulhuddart, Dublin 15
Dublin
Ireland
Responsible manufacturer
Klocke Verpackungs-Service GmbH
Max-Becker-Str. 6
76356 Weingarten (Baden)
Germany
or
Pfizer Manufacturing Deutschland GmbH
Mooswaldallee 1
79108 Freiburg Im Breisgau
Germany
or
Mylan Hungary Kft.
Mylan utca 1
Komárom, 2900
Hungary
Further information about this medicinal product can be obtained by contacting the local representative of the marketing authorization holder:
Viatris Pharmaceuticals, S.L.U.
C/ General Aranaz, 86
28027 Madrid
Spain
This medicinal product is authorized in the Member States of the European Economic Area with the following names:
Name | Country |
Celebra | Denmark, Finland, Iceland, Norway, Sweden |
Celebrex | Austria, Belgium, Cyprus, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Netherlands, Portugal, Spain, United Kingdom |
Last review date of this leaflet:April 2021
Other sources of information
Detailed and updated information about this medicinal product is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.